Foodsmart, a food-as-medicine startup, added $10 million to its Series C, bringing the total to about $40 million, CEO Jason Langheier tells Axios exclusively.
Why it matters: The infusion will further its Foodscripts program, which aims to help patients with nutrition-related chronic illnesses — a task the U.S. Department of Health and Human Services is also taking on.
